|
LQDA | Liquidia Corp |
| Pharmaceutical Preparations |
| Book value per $ invested | $ 0.01 |
| Leverage | 92.01% |
| Market Cap | $ 2.1B |
| PE | 0.00 |
| Dividend Yield | 0.00% |
| Profit | $ -121.6m |
| Margin | -224.40% |
Liquidia Corporation, a biopharmaceutical company, develops, manufactures, and markets various products for the unmet needs of patients in the United States. The company is headquartered in Morrisville, North Carolina.